The NIFTY™ test is a non-invasive prenatal test (commonly termed an NIPT) that screens for Down Syndrome and certain other genetic conditions caused by extra or missing genetic information in the baby’s DNA.
In 2016, a leading company in reproductive genetics, Alexander Bisignano and Santiago Munne, together with a team of computer scientists, engineers, and geneticists, founded Phosphorus to address the larger issues preventing genomics from more widely improving the healthcare ecosystem.
SENTIS™ is a comprehensive screening test for hereditary breast and ovarian cancers. SENTIS™ as a Hereditary Breast and Ovarian (HBOC) panel provides health providers and patients with information on 21 genes associated with Hereditary Breast and Ovarian Cancer (HBOC) based on recent scientific and clinical literature.
Medicine from a twist(m)ed perspective
TWISTMED /verb, ˈtwistmed/
to take an approach in medicine that is out of the ordinary, reflecting the current and future needs of health of one and of the many; being able to percieve and appreciate medicine from a perspective that is not in line with the common standards; having a bold and embrazened touch to healthcare improvement.
Whatever the weather with TwistMed together
Where you can find us ?
|Address:||Miloja Djaka 12B,
|Phone:||+381 (0)11 7345 600|
|Phone:||+382 (0)69 3020 23|
|Address:||Josef Schöffel Straße 2,
|Phone:||+43 (0)664 8633 788|
Get in touch with us